Market Overview:
The global wound care market is projected to reach USD 27.8 billion by 2026 from USD 19.3 billion in 2021, at a CAGR of 7.6% during the forecast period.
Growth Drivers:
Market growth is largely driven by factors such as the growing prevalence of chronic conditions resulting in chronic, surgical, acute, and traumatic wounds; increasing spending on chronic wounds; rising use of regenerative medicine in wound management; and technological advancements. The high growth potential of emerging economies and the growing number of acquisitions by key players have also opened an array of opportunities for the growth of the wound care market.
Geographic Analysis: North America is the largest regional market for wound care market
The global wound care market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest market share. The large share of this regional segment can be attributed to the growing prevalence of chronic conditions resulting in chronic, surgical, and traumatic wounds; the increasing incidence of burn injuries; increasing spending on surgical and chronic wounds; and technological advancements in this region.
To Know More Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=371
Leading Key Players:
The wound care market is highly fragmented and is dominated by various players offering wound care products. The major players in this market are Smith & Nephew Plc (UK), Mölnlycke Health Care AB (Sweden), Baxter International (US), 3M Company (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast A/S (Denmark), Medtronic Plc (Ireland), Ethicon Inc. (US), PAUL HARTMANN AG (Germany), MiMedx Group (US), DeRoyal Industries (US), Organogenesis Holdings (US), Kerecis (Iceland), ACell (US), Lohmann & Rauscher International GmbH & Co. (Germany), Medela AG (Switzerland), Talley Group (England), Pensar Medical (US), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (US), Misonix (US), Zimmer Biomet Holdings (US), DermaRite Industries (US), Medline Industries (US), Advancis Medical LLC (UK), MilLaboratories Pvt. Ltd. (India), Welcare Industries Spa. (ITALY), Wuhan VSD Medical Science & Technology (CHINA), and Haromed BVBA (Belgium).
Smith & Nephew Plc (UK) and 3M Company (US) are leading players in Wound Care Market
3M Company (US) is a leading player across all the regions in wound care market. The company offers a wide range of products ranging from advanced wound care products to traditional and surgical wound care products. 3M is primarily a prominent player in the advanced wound care and NPWT markets, owing to its established presence, strong brand recognition, and broad product portfolio. The company mainly focuses on developing new and innovative products to expand its portfolio and address the unmet needs of healthcare professionals and patients. Some of its subsidiaries are 3M Australia Pty Ltd., 3M Asia Pacific Pte. Ltd. (Singapore), 3M Argentina S.A.C.I.F.I.A., 3M Denmark A/S, 3M Israel Ltd., 3M Canada, and 3M New Zealand.
Smith & Nephew Plc. (UK) is another leader in the wound care market, offering advanced wound care products ranging from dressings, and devices ot topical agenst and active wound care products. Smith & Nephew, has a robust portfolio and a strong geographic presence in key geographies. Over the years, the company has invested significant resources in broadening its product portfolio and enhancing its brand presence, which has made it a dominant player in the wound care market. It has also cultivated a wide and diverse network of suppliers to stave off any possibility of bottlenecks.
